The Roche Investor Relations team would like to invite you to the Roche Diagnostics Investor Day that will take place in London on Wednesday, 22 May 2024, starting at 12:00 BST local time and will finish at 15:30 BST with a reception.

The Roche Diagnostics Investor Day will address the following topics:

  • Mass spectrometry
  • Continuous glucose monitoring
  • Next generation sequencing
  • Point of care
  • Upcoming molecular diagnostics launches
  • Neurology biomarkers in development

Meeting information:
Date/Time (BST):
Wednesday, 22 May 2024
12:00 - 13:00 Registration and lunch
13:00 - 15:30 Presentations & Q&A
15:30 - 16:15 Reception

Venue
etc.venues 133 Houndsditch
133 Houndsditch
London EC3A 7BX
> map

An invitation with the detailed programme and registration form will soon follow.

Best regards,

 
Bruno Eschli
Head of Investor Relations

 
Birgit Masjost
Investor Relations Officer



Roche Investor Relations  
Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com

 
Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com

 
Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com

 
 
 
 
Investor Relations North America  
Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com
 

 


get the latest news and updates to your inbox.